KAPA stock news · Kairos Pharma
Get alerts for KAPA
Follow Kairos Pharma (KAPA) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for KAPA12 health care stocks are changing a lot before the market opens on Thursday.
NeutralThe roundup reports Kairos Pharma shares rose 12.41% before the market opened. It gives no company news to show a change in the business outlook.
12 health care companies saw big changes in their stock prices after the market closed on Wednesday.
NeutralKairos Pharma shares rose 6.81% to $0.93 after hours, but the roundup gives no company news, so its business outlook is unchanged.
Here are 12 health care stocks that changed a lot during Wednesday's trading.
NeutralKairos Pharma shares fell about 21% to $0.91 per share. The story gives no company update, so this move alone does not change what we know about its business.
12 health care companies are changing prices before the market opens on Wednesday.
NeutralKairos Pharma's stock fell 8% to $1.06 per share. The article gives no business news behind the drop, so the share move alone does not change its outlook.
12 health care stocks changed a lot in prices after the market closed on Tuesday.
NeutralKairos Pharma shares fell about 7% after hours, but the article gives no company news. The share-price move alone does not change the company's outlook.
Kairos Pharma aims to fight drug resistance in prostate cancer.
Good for KAPAKairos Pharma reported 17.7 months before cancer worsened with ENV-105 plus apalutamide, versus 2 months with apalutamide alone. The interim result supports the drug, but its revised trial remains unfinished.
12 health care companies saw big price changes during Tuesday's trading.
NeutralKairos Pharma shares fell about 25% during Tuesday's session. The article gives no company news explaining the drop, so it does not change the company's outlook.
Kairos Pharma, LTD. outlines significant changes to the rights of security holders (KAPA).
Good for KAPAKairos Pharma, LTD. has filed a Form 8-K detailing material modifications to the rights of security holders, which may lead to changes in shareholder dynamics and could influence trading activity. Investors should assess the implications of these modifications on their holdings.